Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herpesvirus 1, Human | 5 | 2013 | 64 | 0.740 |
Why?
|
| Keratitis, Herpetic | 2 | 2013 | 18 | 0.490 |
Why?
|
| Oligosaccharides | 1 | 2014 | 29 | 0.430 |
Why?
|
| Arteries | 1 | 2014 | 81 | 0.420 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2014 | 72 | 0.410 |
Why?
|
| Betaine | 1 | 2013 | 7 | 0.410 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2013 | 34 | 0.400 |
Why?
|
| Endothelium, Vascular | 2 | 2014 | 263 | 0.390 |
Why?
|
| Antiviral Agents | 2 | 2013 | 195 | 0.360 |
Why?
|
| Virus Latency | 3 | 2012 | 49 | 0.280 |
Why?
|
| Antineoplastic Agents | 4 | 2018 | 1019 | 0.240 |
Why?
|
| Endothelial Cells | 4 | 2014 | 329 | 0.240 |
Why?
|
| Herpesvirus 4, Human | 1 | 2025 | 36 | 0.230 |
Why?
|
| Chick Embryo | 5 | 2014 | 79 | 0.210 |
Why?
|
| Cyclooxygenase 2 | 2 | 2018 | 107 | 0.200 |
Why?
|
| Financing, Organized | 1 | 2022 | 15 | 0.190 |
Why?
|
| Herpes Simplex | 2 | 2012 | 19 | 0.190 |
Why?
|
| Rabbits | 5 | 2013 | 278 | 0.180 |
Why?
|
| Virus Activation | 2 | 2012 | 38 | 0.180 |
Why?
|
| Stromal Cells | 2 | 2012 | 55 | 0.180 |
Why?
|
| Herpesvirus 8, Human | 2 | 2014 | 25 | 0.180 |
Why?
|
| Host-Pathogen Interactions | 2 | 2014 | 209 | 0.170 |
Why?
|
| Apolipoproteins E | 2 | 2012 | 138 | 0.170 |
Why?
|
| Cell Movement | 4 | 2018 | 655 | 0.160 |
Why?
|
| Animals | 14 | 2016 | 16992 | 0.150 |
Why?
|
| Cell Line, Tumor | 6 | 2018 | 2676 | 0.150 |
Why?
|
| DNA, Viral | 3 | 2025 | 311 | 0.150 |
Why?
|
| Metformin | 1 | 2018 | 75 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2022 | 502 | 0.130 |
Why?
|
| Flow Cytometry | 2 | 2014 | 411 | 0.120 |
Why?
|
| Biology | 1 | 2016 | 20 | 0.120 |
Why?
|
| Models, Educational | 1 | 2016 | 46 | 0.120 |
Why?
|
| Disease Models, Animal | 4 | 2016 | 1596 | 0.120 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2016 | 57 | 0.120 |
Why?
|
| Educational Measurement | 1 | 2016 | 102 | 0.110 |
Why?
|
| Humans | 17 | 2025 | 43102 | 0.110 |
Why?
|
| Antioxidants | 1 | 2018 | 443 | 0.110 |
Why?
|
| Antigen-Presenting Cells | 1 | 2014 | 31 | 0.110 |
Why?
|
| Integrin alpha4 | 1 | 2014 | 2 | 0.110 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 74 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 2 | 2014 | 80 | 0.110 |
Why?
|
| Bibenzyls | 1 | 2014 | 4 | 0.110 |
Why?
|
| Mice | 6 | 2016 | 6644 | 0.110 |
Why?
|
| Tubulin Modulators | 1 | 2014 | 20 | 0.110 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 93 | 0.100 |
Why?
|
| Thiazoles | 1 | 2014 | 76 | 0.100 |
Why?
|
| Cell Communication | 1 | 2014 | 114 | 0.100 |
Why?
|
| Pyridines | 1 | 2014 | 139 | 0.100 |
Why?
|
| Matrix Metalloproteinase 15 | 1 | 2012 | 1 | 0.100 |
Why?
|
| Cornea | 1 | 2013 | 70 | 0.100 |
Why?
|
| Eye Infections, Viral | 1 | 2012 | 4 | 0.100 |
Why?
|
| Virus Shedding | 1 | 2012 | 9 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2018 | 1455 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 81 | 0.090 |
Why?
|
| Adipocytes | 1 | 2012 | 60 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 386 | 0.090 |
Why?
|
| Extracellular Matrix | 1 | 2012 | 131 | 0.090 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 415 | 0.090 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2011 | 11 | 0.090 |
Why?
|
| Saliva | 1 | 2012 | 119 | 0.090 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2011 | 10 | 0.090 |
Why?
|
| Glucose | 1 | 2012 | 244 | 0.090 |
Why?
|
| Multipotent Stem Cells | 1 | 2011 | 16 | 0.090 |
Why?
|
| Keratinocytes | 1 | 2011 | 67 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2014 | 561 | 0.080 |
Why?
|
| Gene Expression Profiling | 3 | 2025 | 704 | 0.080 |
Why?
|
| Minority Groups | 1 | 2016 | 690 | 0.080 |
Why?
|
| Eye | 1 | 2011 | 77 | 0.080 |
Why?
|
| Retina | 1 | 2012 | 289 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 139 | 0.080 |
Why?
|
| Students | 1 | 2016 | 626 | 0.080 |
Why?
|
| Peptides | 1 | 2012 | 372 | 0.080 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 2025 | 113 | 0.080 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 1723 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2011 | 307 | 0.070 |
Why?
|
| Receptors, Chemokine | 1 | 2007 | 72 | 0.070 |
Why?
|
| Hemophilia A | 1 | 2005 | 3 | 0.060 |
Why?
|
| Blood Component Transfusion | 1 | 2005 | 4 | 0.060 |
Why?
|
| HIV Antibodies | 1 | 2005 | 24 | 0.060 |
Why?
|
| Serum | 1 | 2005 | 17 | 0.060 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2025 | 20 | 0.060 |
Why?
|
| Open Reading Frames | 1 | 2025 | 79 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 1869 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2014 | 2157 | 0.060 |
Why?
|
| Genome, Viral | 1 | 2025 | 119 | 0.050 |
Why?
|
| DNA Replication | 1 | 2025 | 148 | 0.050 |
Why?
|
| Obesity | 1 | 2012 | 1151 | 0.050 |
Why?
|
| Dinoprostone | 2 | 2018 | 64 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2025 | 190 | 0.050 |
Why?
|
| Chorioallantoic Membrane | 2 | 2014 | 11 | 0.050 |
Why?
|
| Virus Replication | 1 | 2025 | 318 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2025 | 526 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 2014 | 506 | 0.050 |
Why?
|
| Writing | 1 | 2022 | 42 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2014 | 290 | 0.050 |
Why?
|
| Academies and Institutes | 1 | 2022 | 39 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2025 | 592 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 1070 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2022 | 120 | 0.050 |
Why?
|
| Dipeptides | 2 | 2012 | 31 | 0.050 |
Why?
|
| Recurrence | 2 | 2012 | 152 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2018 | 59 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2012 | 638 | 0.040 |
Why?
|
| Female | 5 | 2018 | 24698 | 0.040 |
Why?
|
| Data Mining | 1 | 2016 | 30 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 532 | 0.030 |
Why?
|
| Cell Line | 2 | 2011 | 1410 | 0.030 |
Why?
|
| Risk | 1 | 2016 | 287 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 310 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 149 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 490 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 95 | 0.030 |
Why?
|
| Colchicine | 1 | 2014 | 15 | 0.030 |
Why?
|
| Laminin | 1 | 2014 | 58 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2014 | 49 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 72 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2014 | 104 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2014 | 62 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2014 | 157 | 0.030 |
Why?
|
| Tubulin | 1 | 2014 | 96 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2014 | 408 | 0.030 |
Why?
|
| Collagen | 1 | 2014 | 181 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 455 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 237 | 0.020 |
Why?
|
| Curriculum | 1 | 2016 | 318 | 0.020 |
Why?
|
| Tears | 1 | 2012 | 11 | 0.020 |
Why?
|
| Drug Design | 1 | 2014 | 186 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2014 | 321 | 0.020 |
Why?
|
| Binding Sites | 1 | 2014 | 671 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2012 | 152 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 286 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 183 | 0.020 |
Why?
|
| Stem Cells | 1 | 2012 | 152 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 532 | 0.020 |
Why?
|
| United States | 1 | 2022 | 5205 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 74 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2011 | 19 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2011 | 49 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2011 | 44 | 0.020 |
Why?
|
| HIV Infections | 1 | 2005 | 2586 | 0.020 |
Why?
|
| Viral Load | 1 | 2012 | 348 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 1621 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 256 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2014 | 876 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 436 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2011 | 283 | 0.020 |
Why?
|
| Aorta | 1 | 2011 | 198 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 652 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 1271 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 518 | 0.010 |
Why?
|
| Proviruses | 1 | 2005 | 35 | 0.010 |
Why?
|
| AIDS Serodiagnosis | 1 | 2005 | 25 | 0.010 |
Why?
|
| Rats | 1 | 2011 | 3735 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2005 | 2544 | 0.010 |
Why?
|
| Male | 1 | 2016 | 23409 | 0.010 |
Why?
|
| Aged | 1 | 2005 | 8214 | 0.010 |
Why?
|
| Middle Aged | 1 | 2005 | 12222 | 0.000 |
Why?
|
| Adult | 1 | 2005 | 13872 | 0.000 |
Why?
|